Expression profiles of MMP-9 and EMMPRIN in chronic rhinosinusitis with nasal polyps

Spyridon Lygeros1, Gerasimos Danielides1, George C Kyriakopoulos2

  • 1Department of Otorhinolaryngology, School of Medicine, University of Patras, Patras, Greece.

Abstract

Insights

Matrix metalloproteinase-9 (MMP-9) mRNA is upregulated in chronic rhinosinusitis with nasal polyps (CRSwNP), suggesting its role in disease pathogenesis. MMP-9 may be a therapeutic target for CRSwNP.

Area of Science:

  • Otorhinolaryngology
  • Molecular Biology
  • Pathology

Background:

  • Matrix metalloproteinases (MMPs) play a role in tissue remodeling.
  • Chronic rhinosinusitis with nasal polyps (CRSwNP) involves significant tissue remodeling.
  • MMP-9 and EMMPRIN are key regulators of extracellular matrix turnover.

Purpose of the Study:

  • To compare the expression of MMP-9 and EMMPRIN in CRSwNP nasal polyps versus healthy nasal mucosa.
  • To investigate the potential role of MMP-9 and EMMPRIN in CRSwNP pathogenesis.

Main Methods:

  • Tissue samples were collected from 37 CRSwNP patients and 12 healthy controls.
  • MMP-9 and EMMPRIN mRNA levels were quantified using RT-PCR.
  • MMP-9 and EMMPRIN protein levels were assessed via Western blot analysis.

Main Results:

  • MMP-9 mRNA levels were significantly higher in CRSwNP tissues compared to controls (p < 0.05).
  • MMP-9 protein levels showed an increasing trend in CRSwNP but did not reach statistical significance.
  • No significant differences in EMMPRIN mRNA or protein levels were observed between CRSwNP and control groups.

Conclusions:

  • Elevated MMP-9 mRNA in CRSwNP indicates its involvement in the disease.
  • The discrepancy between MMP-9 mRNA and protein levels suggests post-transcriptional regulation.
  • While EMMPRIN showed no significant difference, its role in CRSwNP warrants further investigation.
  • MMP-9 presents a potential biomarker and therapeutic target for CRSwNP.